跳至主要内容
临床试验/NCT01540773
NCT01540773已完成不适用

Growth Hormone 120 Minutes Following a Single Low-dose of Amino Acids in Healthy Subjects.

Pennington Biomedical Research Center1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
1
主要终点
Change From Baseline of Growth Hormone

研究概览

简要总结

The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.

详细描述

Oral supplementation with a key combination of derivatives that has been shown to increase human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours post-administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • healthy males and healthy females
  • Between 18 and 70 years

排除标准

  • Pregnant or nursing
  • Taking any chronic medication including birth control pills.

研究组 & 干预措施

amino acid supplement

Active Comparator

supplements with the proprietary amino acid derivative blend.

干预措施: Amino acid supplement (Drug)

Placebo

Placebo Comparator

Non-Active

干预措施: Placebo (Drug)

结局指标

主要结局

Change From Baseline of Growth Hormone

时间窗: 0-120 minutes, at Baseline and post dose, week 1 and week 3

Measure human growth hormone at times 0-120 minutes on two occasions about one week apart. On one occasion, the proprietary amino acid derivative blend will be given orally at time 0 in capsule form, and on the other occasion the capsules will contain no amino acids.

Area Under the Curve of Growth Hormone Over Baseline

时间窗: 0-120 minutes, at Baseline and post dose, week 1 and week 3

Measure human growth hormone at times 0-120 minutes on two occasions about one week apart. On one occasion, the proprietary amino acid derivative blend will be given orally at time 0 in capsule form, and on the other occasion the capsules will contain no amino acids.

次要结局

  • Insulin-like Growth Factor 1(8 hours following administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frank Greenway

Principal Investigator

Pennington Biomedical Research Center

研究点 (1)

Loading locations...

相似试验